Crestwood Advisors Group’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,095
Closed -$245K 275
2022
Q3
$245K Buy
3,095
+248
+9% +$19.6K 0.01% 232
2022
Q2
$211K Sell
2,847
-4,178
-59% -$310K 0.01% 242
2022
Q1
$631K Sell
7,025
-192
-3% -$17.2K 0.02% 189
2021
Q4
$808K Buy
7,217
+92
+1% +$10.3K 0.02% 176
2021
Q3
$896K Sell
7,125
-3,781
-35% -$475K 0.03% 156
2021
Q2
$1.48M Sell
10,906
-1,795
-14% -$243K 0.04% 134
2021
Q1
$1.72M Buy
12,701
+2,874
+29% +$390K 0.05% 123
2020
Q4
$1.38M Sell
9,827
-40
-0.4% -$5.63K 0.05% 130
2020
Q3
$1.1M Buy
9,867
+217
+2% +$24.2K 0.04% 122
2020
Q2
$1.08M Sell
9,650
-60
-0.6% -$6.72K 0.04% 120
2020
Q1
$752K Sell
9,710
-3,630
-27% -$281K 0.04% 130
2019
Q4
$1.27M Buy
13,340
+350
+3% +$33.3K 0.05% 123
2019
Q3
$990K Sell
12,990
-1,450
-10% -$111K 0.04% 130
2019
Q2
$1.27M Buy
14,440
+305
+2% +$26.8K 0.06% 122
2019
Q1
$1.28M Sell
14,135
-1,250
-8% -$113K 0.09% 75
2018
Q4
$1.1M Buy
15,385
+7,635
+99% +$548K 0.09% 74
2018
Q3
$743K Hold
7,750
0.05% 85
2018
Q2
$732K Hold
7,750
0.05% 86
2018
Q1
$680K Hold
7,750
0.05% 88
2017
Q4
$658K Hold
7,750
0.05% 93
2017
Q3
$671K Hold
7,750
0.06% 90
2017
Q2
$618K Hold
7,750
0.05% 89
2017
Q1
$549K Hold
7,750
0.05% 92
2016
Q4
$459K Buy
7,750
+4,000
+107% +$237K 0.04% 105
2016
Q3
$249K Hold
3,750
0.03% 113
2016
Q2
$203K Buy
+3,750
New +$203K 0.03% 128
2016
Q1
Sell
-3,750
Closed -$263K 155
2015
Q4
$263K Hold
3,750
0.03% 123
2015
Q3
$233K Hold
3,750
0.03% 130
2015
Q2
$315K Hold
3,750
0.04% 117
2015
Q1
$282K Hold
3,750
0.04% 112
2014
Q4
$233K Buy
+3,750
New +$233K 0.04% 127